Torrent Pharmaceuticals reports strong Q1 growth, acquires JB Pharma

Torrent Pharmaceuticals reported 11% revenue growth to Rs 3,178 crores for Q1 FY26, with net profit climbing 20% to Rs 548 crores. Operating EBITDA rose 14% to Rs 1,032 crores, yielding a 32.5% margin.

The company announced a definitive agreement to acquire a controlling stake in J.B. Chemicals & Pharmaceuticals Limited in a multi-phase transaction totaling approximately Rs 11,917 crores through equity purchases and subsequent merger.